Taro Pharmaceutical Industries Ltd. (Taro) is a multinational, science-based pharmaceutical company that develops, manufactures and markets prescription and over-the-counter (OTC) pharmaceutical products primarily in the United States, Canada and Israel. It also develops and manufactures active pharmaceutical ingredients (APIs) primarily for use in its finished dosage form products. Its primary areas of focus include topical creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries: Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 20 countries. Taro’s product groups include Amiodarone Hydrochloride, Ammonium Lactate, Carbamazepine and Clobetasol Propionate.